Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplastic Cells, Circulating 2Colorectal Neoplasms 2Neoplasms 1Neoplasm, Residual 1Colonic Neoplasms 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Pirinitramide × Clear all
NCT03700411 2023-12-07

POACC-1

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
125 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT03700541 2023-12-07

POACC-2

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
71 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT02314871 2019-03-13

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
60 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡